BG8

Bivalirudin (BG-8967) is a reversible inhibitor of α- and ζ-thrombin (Kis = 2.56 and 1.84 nM, respectively), enzymes that exhibit high fibrinogen-clotting activities.

Bivalirudin acetate is a thrombin inhibitor, a peptide-based anticoagulant, used for research on acute coronary syndrome.

Bivalirudin TFA is a hirudin analog and belongs to the class of specific, reversible direct thrombin inhibitors. Bivalirudin TFA exhibits high selectivity, with Ki values of 2.56 nM and 1.84 nM for α-thrombin and ζ-thrombin, respectively, and shows no significant activity against trypsin or γ-thrombin. Bivalirudin TFA also exhibits antiviral and anti-inflammatory activities. Bivalirudin TFA can be used in research on thrombotic diseases and other conditions.